OUR MISSION
To transform the efficacy and safety of intracellularly active therapeutics, macromolecules, and biologics across the spectrum of health conditions through the application of our Endosomal Intracellular Penetration & Release (EIPR) platform, TANA-Porter™


OUR TEAM
humble beginnings...

KIET A. LY, MD, MPH, MS
President &
Chief Executive Officer

JEAN PHILIPPE PELLOIS, PHD
Chief Scientific Officer

GLORIA MACEIKO
Executive Advisor - Partnerships

HUCK HOLZ, MD
Chief Medical Officer

CEDRIC G. GEOFFROY, PHD
Associate CSO

CHRIS SARKISS, MD
Head of Therapeutics Development

DAN LEE, MD, PHD
R&D Medical Advisor

RAMIN ZACHARIA
Finance Advisor
